- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| Di | Prenetics Global Limited: Prenetics Announces CEO Danny Yeung Keynote at Token 2049 Singapore | 2 | GlobeNewswire (USA) | ||
| 15.09. | Prenetics CEO tells Investing.com IM8 growth and BTC strategy to drive returns | 1 | Investing.com | ||
| 12.09. | Prenetics Global GAAP EPS of -$0.82, revenue of $17.7M | 1 | Seeking Alpha | ||
| 12.09. | Prenetics raises 2025 revenue guidance as IM8 brand drives growth | 2 | Investing.com | ||
| 12.09. | Prenetics hebt Umsatzprognose für 2025 an - IM8-Marke als Wachstumstreiber | 2 | Investing.com Deutsch | ||
| 12.09. | Prenetics Global Limited: Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year's End | 619 | GlobeNewswire (Europe) | 1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 - $100... ► Artikel lesen | |
| 12.09. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.09. | Prenetics Global Limited: Prenetics' IM8 Congratulates Global Ambassador and Shareholder - World No. 1 Aryna Sabalenka on Defending Her US Open Championship | 2 | GlobeNewswire (USA) | ||
| 22.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 01.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.07. | Prenetics Global Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.06. | Prenetics Global Limited: World No. 1 Tennis Star Aryna Sabalenka Joins Prenetics' IM8 Health as Global Ambassador and Shareholder | 2 | GlobeNewswire (USA) | ||
| 23.06. | Prenetics stock steady as Cantor reiterates rating on divestiture news | 1 | Investing.com | ||
| 23.06. | Prenetics-Aktie stabil: Cantor bekräftigt Bewertung nach Veräußerungsnachricht | 1 | Investing.com Deutsch | ||
| 20.06. | Bitcoin im Gesundheitssektor: Prenetics wagt mutigen Schritt in neue Märkte | 4 | Coin-Update.de | ||
| 18.06. | Bitcoin-Wette: Gesundheitsunternehmen Prenetics investiert $20M, nachdem die Marktkapitalisierung um 94% gesunken ist | 3 | Bitcoin.com News | ||
| 18.06. | Prenetics becomes first healthcare firm to acquire bitcoin for treasury | 1 | Investing.com | ||
| 18.06. | Prenetics Acquires $20 Million In Bitcoin To Boost Healthcare Bitcoin Treasury Strategy | 1 | Benzinga.com | ||
| 18.06. | Prenetics Global Limited: Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board | 2 | GlobeNewswire (USA) | ||
| 18.06. | Prenetics to sell ACT Genomics stake to Delta Electronics for $46 million | 1 | Investing.com |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CANSINO BIOLOGICS | 5,730 | +0,17 % | CANSINOBIO (06185): FORM OF PROXY FOR USE AT THE 2025 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, OCTOBER 23, 2025 | ||
| SINO BIOPHARM | 0,909 | +0,02 % | Guotai Junan Initiates Rating Buy on SINO BIOPHARM w/TP HKD10 | ||
| GENSCRIPT BIOTECH | 1,856 | +1,37 % | GenScript Biotech Corporation: GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation | Rising Global Footprint, Best-in-Class Innovation, and ESG Excellence Set Stage for Sustained Value Creation
PISCATAWAY, N.J., Aug. 17, 2025 /PRNewswire/ --... ► Artikel lesen | |
| QUANTUM-SI | 1,725 | 0,00 % | Quantum-Si schließt At-the-Market-Vertriebsvereinbarung über 100 Mio. US-Dollar mit Leerink Partners | ||
| INNOVENT BIOLOGICS | 10,500 | -2,78 % | INNOVENT BIO (01801): 2025 INTERIM REPORT | ||
| SCILEX | 15,750 | 0,00 % | Scilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant Repurchase | PALO ALTO, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and... ► Artikel lesen | |
| AKESO | 15,700 | +2,61 % | AKESO (09926): 2025 INTERIM REPORT | ||
| ORIGIN AGRITECH | 1,170 | -7,14 % | Origin Agritech Limited: Origin Agritech Announces Investment Agreements, Including Investment from Origin CEO Weibin Yan | BEIJING, Sept. 30, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today... ► Artikel lesen | |
| ADMA BIOLOGICS | 14,660 | 0,00 % | ADMA Biologics, Inc.: ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update | 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted... ► Artikel lesen | |
| CG ONCOLOGY | 39,820 | 0,00 % | CG Oncology Inc.: CG Oncology Completes Enrollment in PIVOT-006 | - Rapid enrollment underscores high unmet need in intermediate-risk non-muscle invasive bladder cancer (NMIBC) -- One of the largest randomized phase 3 studies in this patient population will encompass... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,480 | 0,00 % | Recursion Pharmaceuticals: Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update | SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and... ► Artikel lesen | |
| ARVINAS | 9,610 | 0,00 % | Arvinas Inc.: Arvinas Presents Late Breaking, Positive Phase 1 Clinical Data for ARV-102, a PROTAC LRRK2 Degrader, at the 2025 International Congress of Parkinson's Disease and Movement Disorders | - ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson's disease - - ARV-102 demonstrated dose-dependent cerebrospinal fluid (CSF) exposure in subjects... ► Artikel lesen | |
| IMMUNOME | 12,380 | 0,00 % | Where Immunome Stands With Analysts | ||
| JANUX THERAPEUTICS | 24,000 | 0,00 % | Janux Therapeutics: Günstige Gelegenheit | Janux Therapeutics hat mit seiner innovativen Plattformtechnologie im letzten Jahr das Interesse vieler Investoren geweckt - nicht zuletzt aufgrund von Übernahmegerüchten. Doch unabhängig von einem... ► Artikel lesen | |
| ARS PHARMACEUTICALS | 10,310 | 0,00 % | ARS Pharma secures $250M loan to accelerate Neffy rollout |
PRENETICS GLOBAL LIMITED gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 14,270 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.